Insider Transactions Reported by 17 Insiders of Theseus Pharmaceuticals, Inc.

Location
Cambridge, MA

There are no Buy or Sell transactions made by insiders since 23 Feb 2025

Theseus Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
TAKEDA PHARMACEUTICAL CO LTD 10%+ Owner $4,927,052 12 Oct 2021
Foresite Capital Management V, LLC 10%+ Owner $4,226,766 17 Jul 2023
Omega Fund VI, L.P. Former 10% owner $2,170,011 12 Oct 2021
William Shakespeare President of Research and Development $2,015,007 06 Nov 2023
Rock Springs Capital Management LP 10%+ Owner $1,827,926 12 Oct 2021
TIMOTHY P. CLACKSON President and CEO, Director $139,156 01 Mar 2023
David Kerstein Chief Medical Officer $53,375 01 Mar 2023
Victor Rivera Chief Scientific Officer $49,563 01 Mar 2023
Kathy Yi Director $0 14 Feb 2024
Steven H. Stein Director $0 14 Feb 2024
ORBIMED ADVISORS LLC Director, 10%+ Owner $0 14 Feb 2024
DONALD J. HAYDEN JR Director $0 14 Feb 2024
CARL L. GORDON Director, 10%+ Owner $0 14 Feb 2024
Iain Dukes Director $0 14 Feb 2024
Bradford D. Dahms President and CFO $0 14 Feb 2024
David Dalgarno Chief Technical Officer 18 Feb 2022
Michael E. Rome Director 06 Oct 2021

Recent Insider Transactions by Companies or Individuals for Theseus Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.